Mallinckrodt Institute of Radiology; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.
Mallinckrodt Institute of Radiology.
PET Clin. 2024 Apr;19(2):281-290. doi: 10.1016/j.cpet.2023.12.014.
The clinical landscape of lymphomas has changed dramatically over the last 2 decades, including significant progress made in the understanding and utilization of imaging modalities and the available treatment options for both indolent and aggressive lymphomas. Since the introduction of hybrid PET/CT scanners in 2001, the indications of 18F-fluorodeoxyglucose (FDG) PET/CT in the management of lymphomas have grown rapidly. In today's clinical practice, FDG PET/CT is used in successful management of the vast majority patients with lymphomas.
在过去的 20 年中，淋巴瘤的临床状况发生了巨大变化，包括在理解和利用成像方式以及惰性和侵袭性淋巴瘤的可用治疗方案方面取得了重大进展。自 2001 年推出混合 PET/CT 扫描仪以来，18F-氟脱氧葡萄糖（FDG）PET/CT 在淋巴瘤管理中的应用指征迅速增加。在当今的临床实践中，FDG PET/CT 成功地用于管理绝大多数淋巴瘤患者。
